Lead Product(s) : Iobenguane Sulfate I 123
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Adreview is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 05, 2013
Lead Product(s) : Iobenguane Sulfate I 123
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : GE Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
